If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
SUGAMMADEX ACCORD sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 372777Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Accord Healthcare Pty Ltd
Phone: 1800 222 673
|
From 25 Sep 2025 to 31 Mar 2027
|
Shortage status: Current
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative brands are available.
|
SUGAMMADEX ARX sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 356510Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Phone: 1800 195 055
|
From 26 Oct 2026 to 15 Jan 2027
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: Alternative brands are available.
|
SUGAMMADEX JUNO sugammadex (as sodium) 500 mg/5 mL solution for injection vial AUST R: 387626Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Juno Pharmaceuticals Pty Ltd
Phone: 0388881288
|
From 01 Jan 2027 to 05 Feb 2027
|
Shortage status: Anticipated
Availability: Available
Reason: Unexpected increase in demand due to other sponsors unable to supply
Management action: Alternative brands are available.
|
SUGAMMADEX MEDSURGE sugammadex 200 mg/2 mL solution for injection vial AUST R: 367219Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Medsurge Pharma Pty Ltd
Phone: 0477330626
|
From 27 Feb 2026 to 26 Aug 2026
|
Shortage status: Resolved
Availability: Available
Reason: Manufacturing
|
SUGAMMADEX MEDSURGE sugammadex 500 mg/5 mL solution for injection vial AUST R: 367220Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Medsurge Pharma Pty Ltd
Phone: 1300 788 261
|
From 02 Jun 2026 to 05 Oct 2026
|
Shortage status: Resolved
Availability: Available
Reason: Manufacturing
|
SUGAMMADEX VIATRIS sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 377048Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Alphapharm Pty Ltd
Phone: 1800274276
|
From 27 Aug 2026 to 20 Oct 2026
|
Shortage status: Resolved
Availability: Available
Reason: Manufacturing
|
SUGAMMADEX JUNO sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 387625Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Juno Pharmaceuticals Pty Ltd
Phone: 0388881288
|
Deletion from market:
31 Dec 2026
|
Shortage status: To be discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative brands are available.
|
SUGAMMADEX KABI sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 405171Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Fresenius Kabi Australia Pty Ltd
Phone: 02 9391 5555
|
Deletion from market:
31 Mar 2027
|
Shortage status: To be discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Manufacturing
Management action: Alternative brands are available.
|
SUGAMMADEX LUPIN sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 395866Active ingredients:
sugammadex sodium
Dosage form: Injection
Sponsor: Lupin Australia Pty Limited
Phone: 61 3 9809 7900
|
Deletion from market:
31 Jan 2027
|
Shortage status: To be discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative brands are available.
|
SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial AUST R: 375461Active ingredients:
sugammadex sodium
Dosage form: Injection, solution
Sponsor: Teva Pharma Australia Pty Ltd
Phone: 1800 288 382
|
Deletion from market:
26 Jun 2026
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Manufacturing
Management action: Alternative brands are available.
|